Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Regenx Announces Facility Update
-
Meridianbet Foundation (GMGI) Marks Five Years of Successful Global Scholarship Program
-
A new lens on Guangxi
-
Bitget Wallet Lite Hits 6 Million Users in Days, Now The Largest Telegram Wallet
-
Y-mAbs and Nobelpharma Announce Exclusive License and Distribution Agreement for DANYELZA® (naxitamab-gqgk) in Japan
-
Advancing the Great Atlantic Salt Project: Atlas Salt's Approach to EA Conditions and Permitting
-
New Book Highlights Emerging Therapeutic Uses of Ultrasound Technology in Medical Applications
-
Stillwater Critical Minerals Reports up to 1.13 g/t Rhodium in Drill Results from the Stillwater West PGE-Ni-Cu-Co + Au Project, Montana, USA, and Comments on Bipartisan Support for US Miners
-
Ivanhoe Mines Announces Kamoa-Kakula Achieved Record Copper Production of 41,800 Tonnes in October
-
RIWI Secures $1.3 Million CAD in New Revenues for 12 Months, with Potential for Additional $1.37 Million in Subsequent Year
-
SOL Global Announces Strategic Change with Investment Focus in Solana
-
Western Gold's MT Survey Confirms Depth Potential for Mineralised Copper-Gold Porphyries in Lorne, Scotland
-
FTI Consulting Expands Financial Services Practice with Appointment of Two Senior Managing Directors
-
SingleOps and Landscape Management Network (LMN) Merge Alongside Strategic Growth Investment from FTV Capital
-
Aveanna Healthcare Holdings Announces Appointment of New Director
-
Kazia Therapeutics Announces Granting of Type C Meeting with FDA to Discuss Potential Next Steps for Paxalisib in the Treatment of Newly Diagnosed Glioblastoma Multiforme
-
Actinium Pharmaceuticals Appoints Accomplished Biopharma Industry Executive June Almenoff, M.D., Ph.D. to its Board of Directors
-
PSEG ANNOUNCES THIRD QUARTER 2024 RESULTS
-
Apogee Therapeutics to Participate in Upcoming November Investor Conferences
-
Altimmune to Report Third Quarter 2024 Financial Results and Provide Business Update on November 12, 2024
-
COVE COMMUNITIES POISED FOR CONTINUED GROWTH
-
SOUTHWEST AIRLINES NAMES RAKESH GANGWAL CHAIR OF THE BOARD AND ANNOUNCES NEW COMMITTEE CHAIRS
-
Renovus Capital Partners Announces Majority Investment in Performive
-
HelixVM™ Featured in Prestigious JMIR Publication, Recognized as GrowFL Award Finalist
-
Scripps reports Q3 2024 financial results
-
Palatin Presents Data on Novel Melanocortin 4 Receptor Selective Oral Small Molecule PL7737 Obesity Program at ObesityWeek® 2024
-
CME Group Reports October 2024 ADV of 24.3 Million Contracts
-
Angitia Biopharmaceuticals Announces Dosing of First Patient in Phase 2 Clinical Trial of AGA2118 for the Treatment of Osteoporosis
-
HYZON ANNOUNCES COMPLETION OF SUCCESSFUL TRIAL OF 200kW CLASS 8 FCEV TRUCK WITH IMC LOGISTICS
-
HiFiBiO Therapeutics Receives FDA Clearance of IND Application for HFB200604, a Best-in-Class BTLA Agonist Antibody for the Treatment of Inflammatory and Immunology Diseases
-
Hertz Global Holdings, Inc. to Announce Third Quarter 2024 Financial Results on November 12, 2024
-
Frontdoor Announces Record Third-Quarter 2024 Results
-
Neurogene Announces Oversubscribed $200 Million Private Placement
-
Satellos to Participate in November 2024 Investor Conferences
-
Blue Earth Diagnostics, a Bracco Company, Applauds New CMS Rule to Support Patient Access Through Improved Payment for Specialized Diagnostic Radiopharmaceuticals
-
SelectQuote, Inc. Reports First Quarter of Fiscal Year 2025 Results
-
Enfusion Announces Third Quarter 2024 Results
-
Atlantic International Corp. and Staffing 360 Solutions, Inc. Enter Into Definitive Merger Agreement to Establish Leading Human Capital Management, Outsourced Services and Workforce Solutions Company
-
Industry Veteran Joe Ballarino Brings 400 Agents to Real
-
VIQ Solutions Announces Term Loan and Fourth Amendment to Credit Facility
-
Energy Vault Announces Compliance with NYSE Continued Listing Criteria
-
Arrowhead Pharmaceuticals to Participate in Upcoming November 2024 Conferences
-
Centessa Pharmaceuticals to Participate in Upcoming Investor Conferences
-
Emergent BioSolutions Appoints Dr. Simon Lowry as Chief Medical Officer and Head of Research and Development
-
ZenaTech Announces Dual Listing of Its Shares on the Frankfurt Stock Exchange
-
Legend Biotech Appoints Alan Bash as President of CARVYKTI®
-
Scorpius Holdings Announces Collaboration with Celltheon Corporation, a U.S.-Based Cell Line Development Company; First Client Signed Under New Partnership Agreement
-
Skyharbour Enters into Agreements to Partner with Hatchet Uranium Corp. on Several of its Uranium Projects Located in the Athabasca Basin, Saskatchewan
-
Conduit Pharmaceuticals Announces New Addition to its Autoimmune Pipeline
-
Editas Medicine Announces Third Quarter 2024 Results and Business Updates

